Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023
Ralf Otto-Knapp, Askar Yedilbayev(World Health Organization Regional Office for Europe), Brit Häcker, Stefan Kröger(Robert Koch Institute), Stela Bivol(World Health Organization Regional Office for Europe), Giorgi Kuchukhidze(World Health Organization Regional Office for Europe), Suzanne Edwards(Technische Universität Berlin)
Cited by 11
Related Papers
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
|PubMed|2006|94
<i>Treating Multidrug‐Resistant Tuberculosis in Tomsk, Russia</i>
|Annals of the New York Academy of Sciences|2008|59
Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
|Clinical Infectious Diseases|2014|51